What if we could diagnose Periodontal Disease much earlier than today?
What if we could diagnose Periodontal Disease much earlier than today? What if the new standard of early diagnostics is
February 19, 2020
We are here to bridge the gap between science and people. We embrace curiosity while working with partner scientists to develop antibodies for use in in-vitro diagnostics (IVD) and immunological assays.
We bring the best products to the right people. Faster, more efficient, more people to benefit. Together, let’s bring science to the people.
Scroll to know more.
Innovation begins with curiosity and collaboration. Facilitating the process from idea to research to development of antibodies is key to successful business endeavours. Today for tomorrow.
What if we could diagnose Periodontal Disease much earlier than today? What if the new standard of early diagnostics is
One of the best take-home messages from the #ECCO2020 conference is that #calprotectin is a superior biomarker for colorectal inflammation. But it also seems
Mass Spectrometry is going to be a corner stone in the innovation at Ovodan Biotech A/S and the Innovation Fund Denmark agrees. They have
Periodontitis and Rheumatoid Arthritis are diseases related to the same enzymatical activity. To investigate this the Ovodan Biotech A/S R&D team
To solve the problems of tomorrow, we need to be curious. Our business and our business model evolve around curiosity. It’s a part of who we are today and who we want to be in the future.